Australian-New Zealand Clinical Trial: Efficacy and safety of prehospital fibrinogen early in severe trauma study: A feasibility and two arm phase II study (PRE-FEISTY II)(Stage 2).

Australia, Oct. 28 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Efficacy and safety of prehospital fibrinogen early in severe trauma study: A feasibility and two arm phase II study (PRE-FEISTY II)(Stage 2).’. The following are the other relevant details related to the trial:

Trial ID: 386246

Submit Date: 10/16/26 11:23

Study Type: Interventional

Intervention: Intravenous or intraosseous adminstration of three vials (approximately 3g) of fibrinogen concentrate (RiaStap®) following the conclusion of initial resuscitation and stabilisation, anticipated to be in the timeframe of 15-60 minutes following the arrival of a prehospital medical team. The intervention will be del...